6.
Mesguich C, Hulin C, Latrabe V, Lascaux A, Bordenave L, Hindie E
. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma. Ann Hematol. 2020; 99(12):2869-2880.
DOI: 10.1007/s00277-020-04265-2.
View
7.
Liu X, Zhu Z, Wang K, Zhang Y, Li J, Wang X
. Semiautomated pelvic lymph node treatment response evaluation for patients with advanced prostate cancer: based on MET-RADS-P guidelines. Cancer Imaging. 2023; 23(1):7.
PMC: 9847043.
DOI: 10.1186/s40644-023-00523-4.
View
8.
Pawlyn C, Fowkes L, Otero S, Jones J, Boyd K, Davies F
. Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?. Leukemia. 2015; 30(6):1446-8.
PMC: 4895156.
DOI: 10.1038/leu.2015.338.
View
9.
Li B, Li Q, Nie W, Liu S
. Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis. Eur J Radiol. 2013; 83(2):338-44.
DOI: 10.1016/j.ejrad.2013.11.017.
View
10.
Walker R, Kessar P, Blanchard R, Dimasi M, Harper K, DeCarvalho V
. Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience. J Magn Reson Imaging. 2000; 11(4):343-50.
DOI: 10.1002/(sici)1522-2586(200004)11:4<343::aid-jmri1>3.0.co;2-p.
View
11.
Conti L, Mazzoni D, Marzorati C, Grasso R, Busacchio D, Petralia G
. Observations Regarding the Detection of Abnormal Findings Following a Cancer Screening Whole-Body MRI in Asymptomatic Subjects: The Psychological Consequences and the Role of Personality Traits Over Time. J Magn Reson Imaging. 2024; 61(2):634-645.
PMC: 11706315.
DOI: 10.1002/jmri.29461.
View
12.
Morone M, Antonietta Bali M, Tunariu N, Messiou C, Blackledge M, Grazioli L
. Whole-Body MRI: Current Applications in Oncology. AJR Am J Roentgenol. 2017; 209(6):W336-W349.
DOI: 10.2214/AJR.17.17984.
View
13.
Summers P, Saia G, Colombo A, Pricolo P, Zugni F, Alessi S
. Whole-body magnetic resonance imaging: technique, guidelines and key applications. Ecancermedicalscience. 2021; 15:1164.
PMC: 7929776.
DOI: 10.3332/ecancer.2021.1164.
View
14.
Mesguich C, Latrabe V, Hulin C, Lascaux A, Bordenave L, Hindie E
. Prospective Comparison of 18-FDG PET/CT and Whole-Body MRI with Diffusion-Weighted Imaging in the Evaluation of Treatment Response of Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplant. Cancers (Basel). 2021; 13(8).
PMC: 8074107.
DOI: 10.3390/cancers13081938.
View
15.
Agarwal G, Nador G, Varghese S, Getu H, Palmer C, Watson E
. Prospective Assessment of Tumour Burden and Bone Disease in Plasma Cell Dyscrasias Using DW-MRI and Exploratory Bone Biomarkers. Cancers (Basel). 2023; 15(1).
PMC: 9817825.
DOI: 10.3390/cancers15010095.
View
16.
Hillengass J, Usmani S, Rajkumar S, Durie B, Mateos M, Lonial S
. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol. 2019; 20(6):e302-e312.
DOI: 10.1016/S1470-2045(19)30309-2.
View
17.
Yamamoto S, Yoshida S, Ishii C, Takahara T, Arita Y, Fukushima H
. Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer. J Magn Reson Imaging. 2021; 54(2):401-408.
DOI: 10.1002/jmri.27596.
View
18.
Rossi F, Torri L, Dominietto A, Tagliafico A
. Spectrum of magnetic resonance imaging findings in transplanted multiple myeloma patients with hip/pelvic pain (according to MY-RADS): A single center experience. Eur J Radiol. 2020; 130:109154.
DOI: 10.1016/j.ejrad.2020.109154.
View
19.
Padhani A, Lecouvet F, Tunariu N, Koh D, De Keyzer F, Collins D
. METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer. Eur Urol. 2016; 71(1):81-92.
PMC: 5176005.
DOI: 10.1016/j.eururo.2016.05.033.
View
20.
Giles S, Messiou C, Collins D, Morgan V, Simpkin C, West S
. Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma. Radiology. 2014; 271(3):785-94.
DOI: 10.1148/radiol.13131529.
View